Invention Grant
- Patent Title: Hydrocortisone acetate suppository formulation for treatment of disease
-
Application No.: US16856806Application Date: 2020-04-23
-
Publication No.: US11376217B2Publication Date: 2022-07-05
- Inventor: Jennifer J. Davagian , Raj Devarajan
- Applicant: Cristcot LLC
- Applicant Address: US MA Concord
- Assignee: Cristcot LLC
- Current Assignee: Cristcot LLC
- Current Assignee Address: US MA Concord
- Agency: Hamilton, Brook, Smith & Reynolds, P.C.
- Main IPC: A61K9/02
- IPC: A61K9/02 ; A61K47/02 ; A61K9/00 ; A61M31/00 ; A61K31/573 ; A61K47/10 ; A61K47/14 ; A61K47/20
Abstract:
The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.
Public/Granted literature
- US20200315963A1 Hydrocortisone Acetate Suppository Formulation For Treatment Of Disease Public/Granted day:2020-10-08
Information query
